Eledon Pharmaceuticals Inc (ELDN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $178.63M
Last updated: Nov 17, 2026 at 11:05 AM ET
Eledon Pharmaceuticals Inc (ELDN) Competitors
The companies most similar to Eledon Pharmaceuticals are Equillium (EQ), Sionna Therapeutics, Inc. Common Stock (SION) and Oramed Pharmaceuticals (ORMP). By market cap, Eledon Pharmaceuticals ranks 6th of the 13 companies on this page; Prelude Therapeutics (PRLD) is the largest at $275.32M.
Peer Comparison
ELDN's revenue growth of 0.0% is above the peer median of -48.1%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Eledon Pharmaceuticals (ELDN) | $178.63M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Equillium Inc (EQ) | $106.20M | N/A | 29.3x | 0.0% | N/A | -52.3% | 0.00% |
| Sionna Therapeutics, Inc. Common Stock (SION) | $150.63M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Oramed Pharmaceuticals Inc (ORMP) | $161.33M | 4.3x | N/A | 0.0% | N/A | -100.0% | 6.41% |
| Lineage Cell Therapeutics Inc (LCTX) | $231.35M | N/A | 18.7x | 16.2% | -6.7% | -61.0% | 0.00% |
| Invivyd Inc. (IVVD) | $171.58M | N/A | 2.9x | -183.9% | N/A | 21.2% | 0.00% |
| enGene Therapeutics Inc. (ENGN) | $161.51M | N/A | N/A | 0.0% | -42.2% | 0.0% | 0.00% |
| LENZ Therapeutics Inc (LENZ) | $129.77M | N/A | 9.7x | 0.0% | N/A | -72.9% | 0.00% |
| Immuneering Corp (IMRX) | $240.27M | N/A | N/A | 0.0% | N/A | -99.8% | 0.00% |
| NeOnc Technologies Holdings, Inc. Common Stock (NTHI) | $141.66M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Prelude Therapeutics Inc (PRLD) | $275.32M | N/A | 16.3x | -269.7% | N/A | 41.0% | 0.00% |
| Protalix Biotherapeutics Inc (PLX) | $257.17M | 12.1x | 2.9x | 24.3% | N/A | 22.8% | 0.00% |
| Entrada Therapeutics Inc (TRDA) | $199.28M | N/A | 53.3x | 0.0% | -69.7% | -43.9% | 0.00% |
| Peer median | $166.54M | 8.2x | 16.3x | 0.0% | -42.2% | -48.1% | 0.00% |
Similar Companies
These are the 12 companies most similar to Eledon Pharmaceuticals, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Equillium Inc (EQ) | Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory or immuno-inflammatory... | EQ competitors |
| Sionna Therapeutics, Inc. Common Stock (SION) | Sionna Therapeutics, Inc. is an innovative biotechnology company focused on developing advanced therapies for neurodegenerative disorders... | SION competitors |
| Oramed Pharmaceuticals Inc (ORMP) | Oramed Pharmaceuticals Inc. is dedicated to the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally... | ORMP competitors |
| Lineage Cell Therapeutics Inc (LCTX) | Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapeutics for the treatment... | LCTX competitors |
| Invivyd Inc. (IVVD) | Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery... | IVVD competitors |
| enGene Therapeutics Inc. (ENGN) | enGene Holdings Inc., through its subsidiary enGene, Inc., is a clinical-stage biotechnology company that develops genetic medicines through the delivery... | ENGN competitors |
| LENZ Therapeutics Inc (LENZ) | LENZ Therapeutics Inc is a cutting-edge biopharmaceutical company dedicated to developing transformative therapies for neurological disorders... | LENZ competitors |
| Immuneering Corp (IMRX) | Immuneering Corp (IMRX) is a cutting-edge biotechnology firm dedicated to advancing targeted therapeutics for cancer and other critical illnesses through its... | IMRX competitors |
| NeOnc Technologies Holdings, Inc. Common Stock (NTHI) | NeOnc Technologies Holdings, Inc. is a pioneering biotechnology firm dedicated to revolutionizing cancer treatment through its advanced immunotherapy... | NTHI competitors |
| Prelude Therapeutics Inc (PRLD) | Prelude Therapeutics Incorporated, a precision clinical-stage oncology company, focuses on the discovery and development of small molecule therapies optimized... | PRLD competitors |
| Protalix Biotherapeutics Inc (PLX) | Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its... | PLX competitors |
| Entrada Therapeutics Inc (TRDA) | Entrada Therapeutics Inc. (TRDA) is a forward-thinking biotechnology company focused on creating innovative therapies for severe diseases characterized by... | TRDA competitors |
Frequently Asked Questions About ELDN
Who are Eledon Pharmaceuticals' main competitors?
The companies most similar to Eledon Pharmaceuticals include Equillium (EQ), Sionna Therapeutics, Inc. Common Stock (SION), Oramed Pharmaceuticals (ORMP), Lineage Cell Therapeutics (LCTX) and Invivyd (IVVD), listed from the closest match.
Who is Eledon Pharmaceuticals' biggest competitor?
Prelude Therapeutics (PRLD) is the largest of the similar companies at $275.32M; Equillium (EQ) is the closest match by business profile, size, sector and industry.
How does ELDN stock compare with its competitors?
ELDN's net margin is 0.0% against a peer median of 0.0%.
Which of Eledon Pharmaceuticals' competitors pays a higher dividend?
Eledon Pharmaceuticals pays no dividend. Oramed Pharmaceuticals (ORMP) has a higher forward dividend yield; Oramed Pharmaceuticals (ORMP) has the highest at 6.41%.
Is Eledon Pharmaceuticals bigger than its competitors?
No. Eledon Pharmaceuticals is 6th by market cap among the 13 companies on this page; the largest is Prelude Therapeutics (PRLD) at $275.32M.
ELDN pages: Overview, Earnings, Forecast, Financials, Competitors